Researcher.Life Logo

Ophthalmology and Therapy : Impact Factor & More

eISSN: 2193-6528pISSN: 2193-8245
JournalOpen Access

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q1Ophthalmology
SNIP
1.7
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Ophthalmology and Therapy

Ophthalmology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER INT PUBL AG
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Ophthalmology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Ophthalmology and Therapy

Scheimpflug Photography-Based Evaluation of Structural Iris Changes Across Keratoconus Stages in Comparison with Healthy Eyes.
  • 27 Apr 2026
  • Ophthalmology and therapy
Rapid Effects on Anatomical and Functional Outcomes following Upload with Faricimab in Treatment-Naïve nAMD: German Single-Center Study 45DRY.
  • 25 Apr 2026
  • Ophthalmology and therapy
Visual Outcomes Following Infectious Endophthalmitis from Intravitreal Injections of Biologic Drugs: An Intelligent Research in Sight Registry Retrospective Analysis.
  • 25 Apr 2026
  • Ophthalmology and therapy
Surgical Management of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES): A Comprehensive Review.
  • 22 Apr 2026
  • Ophthalmology and therapy
Response to "Letter to the Editor Regarding 'Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration'".
  • 18 Apr 2026
  • Ophthalmology and therapy
Letter to the Editor Regarding "Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration".
  • 18 Apr 2026
  • Ophthalmology and therapy
Scheimpflug Photography-Based Evaluation of Structural Iris Changes Across Keratoconus Stages in Comparison with Healthy Eyes.
  • 27 Apr 2026
  • Ophthalmology and therapy
Rapid Effects on Anatomical and Functional Outcomes following Upload with Faricimab in Treatment-Naïve nAMD: German Single-Center Study 45DRY.
  • 25 Apr 2026
  • Ophthalmology and therapy
Visual Outcomes Following Infectious Endophthalmitis from Intravitreal Injections of Biologic Drugs: An Intelligent Research in Sight Registry Retrospective Analysis.
  • 25 Apr 2026
  • Ophthalmology and therapy
Surgical Management of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES): A Comprehensive Review.
  • 22 Apr 2026
  • Ophthalmology and therapy
Response to "Letter to the Editor Regarding 'Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration'".
  • 18 Apr 2026
  • Ophthalmology and therapy
Letter to the Editor Regarding "Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration".
  • 18 Apr 2026
  • Ophthalmology and therapy

FAQs on Ophthalmology and Therapy